{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:56:10Z","timestamp":1790787370112,"version":"4.1.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-025-02164-8","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:37:08Z","timestamp":1767875828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of pyroptosis during HIV infection"],"prefix":"10.1007","volume":"75","author":[{"given":"Mahmoud M.","family":"Yaseen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar M.","family":"Abuharfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Darmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed N.","family":"Shatnawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2164_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00705-017-3569-9","volume":"163","author":"MM Yaseen","year":"2018","unstructured":"Yaseen MM, Abuharfeil NM, Yaseen MM, Shabsoug BM. The role of polymorphonuclear neutrophils during HIV-1 infection. Arch Virol. 2018;163:1\u201321.","journal-title":"Arch Virol"},{"key":"2164_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11904-023-00684-8","volume":"20","author":"MM Yaseen","year":"2023","unstructured":"Yaseen MM, Abuharfeil NM, Darmani H. The role of p53 in HIV infection. Curr HIV\/AIDS Rep. 2023;20:419\u201327.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2164_CR3","doi-asserted-by":"publisher","first-page":"e2400","DOI":"10.1002\/rmv.2400","volume":"33","author":"MM Yaseen","year":"2023","unstructured":"Yaseen MM, Abuharfeil NM, Darmani H. The role of IL-1beta during human immunodeficiency virus type 1 infection. Rev Med Virol. 2023;33:e2400.","journal-title":"Rev Med Virol"},{"key":"2164_CR4","doi-asserted-by":"publisher","first-page":"210216","DOI":"10.1098\/rsob.210216","volume":"11","author":"MM Yaseen","year":"2021","unstructured":"Yaseen MM, Abuharfeil NM, Darmani H. Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection. Open Biol. 2021;11:210216.","journal-title":"Open Biol"},{"key":"2164_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1089\/vim.2017.0065","volume":"30","author":"MM Yaseen","year":"2017","unstructured":"Yaseen MM, Abuharfeil NM, Alqudah MA, Yaseen MM. Mechanisms and factors that drive extensive human immunodeficiency virus Type-1 hypervariability: an overview. Viral Immunol. 2017;30:708\u201326.","journal-title":"Viral Immunol"},{"key":"2164_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hivar.2015.07.004","volume":"15","author":"MAY Alqudah","year":"2016","unstructured":"Alqudah MAY, Yaseen MMM, Yaseen MMS. HIV-1 strategies to overcome the immune system by evading and invading innate immune system. HIV AIDS Rev. 2016;15:1\u201312.","journal-title":"HIV AIDS Rev"},{"key":"2164_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1021\/acsinfecdis.8b00167","volume":"5","author":"NM Abuharfeil","year":"2019","unstructured":"Abuharfeil NM, Yaseen MM, Alsheyab FM. Harnessing Antibody-Dependent cellular cytotoxicity to control HIV-1 infection. ACS Infect Dis. 2019;5:158\u201376.","journal-title":"ACS Infect Dis"},{"key":"2164_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08830185.2016.1225301","volume":"36","author":"MM Yaseen","year":"2017","unstructured":"Yaseen MM, Yaseen MM, Alqudah MA. Broadly neutralizing antibodies: an approach to control HIV-1 infection. Int Rev Immunol. 2017;36:31\u201340.","journal-title":"Int Rev Immunol"},{"key":"2164_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1089\/vim.2021.0115","volume":"34","author":"MM Yaseen","year":"2021","unstructured":"Yaseen MM, Abuharfeil NM, Homa D. Anatomical distribution of Myeloid-Derived suppressor cells during HIV infection. Viral Immunol. 2021;34:673\u20138.","journal-title":"Viral Immunol"},{"key":"2164_CR10","doi-asserted-by":"publisher","first-page":"104440","DOI":"10.1016\/j.cellimm.2021.104440","volume":"369","author":"MM Yaseen","year":"2021","unstructured":"Yaseen MM, Abuharfeil NM, Darmani H. The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines. Cell Immunol. 2021;369:104440.","journal-title":"Cell Immunol"},{"key":"2164_CR11","doi-asserted-by":"publisher","first-page":"104554","DOI":"10.1016\/j.cellimm.2022.104554","volume":"377","author":"M Mohammad Yaseen","year":"2022","unstructured":"Mohammad Yaseen M, Mohammad Abuharfeil N, Darmani H. T-cell evasion and invasion during HIV-1 infection: the role of HIV-1 Tat protein. Cell Immunol. 2022;377:104554.","journal-title":"Cell Immunol"},{"key":"2164_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/COH.0000000000000588","volume":"15","author":"N Phanuphak","year":"2020","unstructured":"Phanuphak N, Gulick RM. HIV treatment and prevention 2019: current standards of care. Curr Opin HIV AIDS. 2020;15:4\u201312.","journal-title":"Curr Opin HIV AIDS"},{"key":"2164_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830\u20139.","journal-title":"N Engl J Med"},{"key":"2164_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-med-110918-034551","volume":"71","author":"MS Cohen","year":"2020","unstructured":"Cohen MS, Gamble T, McCauley M. Prevention of HIV transmission and the HPTN 052 study. Annu Rev Med. 2020;71:347\u201360.","journal-title":"Annu Rev Med"},{"key":"2164_CR15","doi-asserted-by":"publisher","first-page":"e0233341","DOI":"10.1371\/journal.pone.0233341","volume":"15","author":"A Agabu","year":"2020","unstructured":"Agabu A, Baughman AL, Fischer-Walker C, et al. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia. PLoS ONE. 2020;15:e0233341.","journal-title":"PLoS ONE"},{"key":"2164_CR16","doi-asserted-by":"publisher","first-page":"100238","DOI":"10.1016\/j.crmeth.2022.100238","volume":"2","author":"EH Kim","year":"2022","unstructured":"Kim EH, Manganaro L, Schotsaert M, et al. Development of an HIV reporter virus that identifies latently infected CD4(+) T cells. Cell Rep Methods. 2022;2:100238.","journal-title":"Cell Rep Methods"},{"key":"2164_CR17","doi-asserted-by":"publisher","first-page":"16934","DOI":"10.1073\/pnas.1002894107","volume":"107","author":"PU Cameron","year":"2010","unstructured":"Cameron PU, Saleh S, Sallmann G, et al. Establishment of HIV-1 latency in resting CD4\u2009+\u2009T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci U S A. 2010;107:16934\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2164_CR18","doi-asserted-by":"crossref","unstructured":"Zicari S, Sessa L, Cotugno N et al. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected patients under Long-Term ART. Viruses. 2019; 11; 200.","DOI":"10.3390\/v11030200"},{"key":"2164_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/gerona\/glt168","volume":"69","author":"S Pathai","year":"2014","unstructured":"Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol Biol Sci Med Sci. 2014;69:833\u201342.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"2164_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","volume":"62","author":"SG Deeks","year":"2011","unstructured":"Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141\u201355.","journal-title":"Annu Rev Med"},{"key":"2164_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh G, Galloway NL, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505:509\u201314.","journal-title":"Nature"},{"key":"2164_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2015.09.010","volume":"18","author":"I Munoz-Arias","year":"2015","unstructured":"Munoz-Arias I, Doitsh G, Yang Z, et al. Blood-Derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection. Cell Host Microbe. 2015;18:463\u201370.","journal-title":"Cell Host Microbe"},{"key":"2164_CR23","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park W, Wei S, Kim BS, et al. Diversity and complexity of cell death: a historical review. Exp Mol Med. 2023;55:1573\u201394.","journal-title":"Exp Mol Med"},{"key":"2164_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41420-023-01581-0","volume":"9","author":"S Shen","year":"2023","unstructured":"Shen S, Shao Y, Li C. Different types of cell death and their shift in shaping disease. Cell Death Discov. 2023;9:284.","journal-title":"Cell Death Discov"},{"key":"2164_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","volume":"35","author":"P Broz","year":"2025","unstructured":"Broz P. Pyroptosis: molecular mechanisms and roles in disease. Cell Res. 2025;35:334\u201344.","journal-title":"Cell Res"},{"key":"2164_CR26","doi-asserted-by":"crossref","unstructured":"Tang L, Liu S, Li S et al. Induction mechanism of Ferroptosis, Necroptosis, and pyroptosis: A novel therapeutic target in nervous system diseases. Int J Mol Sci 2023; 24.","DOI":"10.3390\/ijms241210127"},{"key":"2164_CR27","doi-asserted-by":"publisher","first-page":"e2300824","DOI":"10.1002\/advs.202300824","volume":"10","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li S, Ferroptosis. Necroptosis, and pyroptosis in Gastrointestinal cancers: the chief culprits of tumor progression and drug resistance. Adv Sci (Weinh). 2023;10:e2300824.","journal-title":"Adv Sci (Weinh)"},{"key":"2164_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41417-024-00765-9","volume":"31","author":"J Gao","year":"2024","unstructured":"Gao J, Xiong A, Liu J, et al. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer Gene Ther. 2024;31:970\u201383.","journal-title":"Cancer Gene Ther"},{"key":"2164_CR29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/cr.2016.100","volume":"26","author":"X Chen","year":"2016","unstructured":"Chen X, He WT, Hu L, et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016;26:1007\u201320.","journal-title":"Cell Res"},{"key":"2164_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","volume":"28","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Chen X, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res. 2018;28:9\u201321.","journal-title":"Cell Res"},{"key":"2164_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1042\/BST20200696","volume":"49","author":"GK Atkin-Smith","year":"2021","unstructured":"Atkin-Smith GK. Phagocytic clearance of apoptotic, necrotic, necroptotic and pyroptotic cells. Biochem Soc Trans. 2021;49:793\u2013804.","journal-title":"Biochem Soc Trans"},{"key":"2164_CR32","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res. 2015;25:1285\u201398.","journal-title":"Cell Res"},{"key":"2164_CR33","doi-asserted-by":"publisher","first-page":"1178662","DOI":"10.3389\/fimmu.2023.1178662","volume":"14","author":"Z Dai","year":"2023","unstructured":"Dai Z, Liu WC, Chen XY, et al. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol. 2023;14:1178662.","journal-title":"Front Immunol"},{"key":"2164_CR34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"2164_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41418-018-0106-7","volume":"26","author":"NM de Vasconcelos","year":"2019","unstructured":"de Vasconcelos NM, Van Opdenbosch N, Van Gorp H, et al. Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture. Cell Death Differ. 2019;26:146\u201361.","journal-title":"Cell Death Differ"},{"key":"2164_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153\u20138.","journal-title":"Nature"},{"key":"2164_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"2164_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/imr.12903","volume":"297","author":"P Kumari","year":"2020","unstructured":"Kumari P, Russo AJ, Shivcharan S, Rathinam VA. AIM2 in health and disease: inflammasome and beyond. Immunol Rev. 2020;297:83\u201395.","journal-title":"Immunol Rev"},{"key":"2164_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"2164_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.molimm.2011.11.004","volume":"49","author":"S Veeranki","year":"2012","unstructured":"Veeranki S, Choubey D. Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol Immunol. 2012;49:567\u201371.","journal-title":"Mol Immunol"},{"key":"2164_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic DsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458:514\u20138.","journal-title":"Nature"},{"key":"2164_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","volume":"143","author":"G Doitsh","year":"2010","unstructured":"Doitsh G, Cavrois M, Lassen KG, et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010;143:789\u2013801.","journal-title":"Cell"},{"key":"2164_CR43","doi-asserted-by":"crossref","unstructured":"Luo X, Herzig E, Doitsh G et al. HIV-2 depletes CD4 T cells through pyroptosis despite Vpx-Dependent degradation of SAMHD1. J Virol 2019; 93.","DOI":"10.1128\/JVI.00666-19"},{"key":"2164_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1243640","volume":"343","author":"KM Monroe","year":"2014","unstructured":"Monroe KM, Yang Z, Johnson JR, et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science. 2014;343:428\u201332.","journal-title":"Science"},{"key":"2164_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s15010-024-02429-0","volume":"53","author":"X Han","year":"2025","unstructured":"Han X, Wang X, Han F, et al. The cGAS-STING pathway in HIV-1 and Mycobacterium tuberculosis coinfection. Infection. 2025;53:495\u2013511.","journal-title":"Infection"},{"key":"2164_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","volume":"19","author":"G Doitsh","year":"2016","unstructured":"Doitsh G, Greene WC. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe. 2016;19:280\u201391.","journal-title":"Cell Host Microbe"},{"key":"2164_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1742-4690-9-87","volume":"9","author":"B Descours","year":"2012","unstructured":"Descours B, Cribier A, Chable-Bessia C, et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology. 2012;9:87.","journal-title":"Retrovirology"},{"key":"2164_CR48","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.celrep.2015.08.011","volume":"12","author":"NL Galloway","year":"2015","unstructured":"Galloway NL, Doitsh G, Monroe KM, et al. Cell-to-Cell transmission of HIV-1 is required to trigger pyroptotic death of Lymphoid-Tissue-Derived CD4 T cells. Cell Rep. 2015;12:1555\u201363.","journal-title":"Cell Rep"},{"key":"2164_CR49","doi-asserted-by":"publisher","first-page":"E4571","DOI":"10.1073\/pnas.1311669110","volume":"110","author":"MR Jakobsen","year":"2013","unstructured":"Jakobsen MR, Bak RO, Andersen A, et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A. 2013;110:E4571\u20134580.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2164_CR50","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012\u201321.","journal-title":"Trends Biochem Sci"},{"key":"2164_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1600-065X.2011.01053.x","volume":"243","author":"SA Schattgen","year":"2011","unstructured":"Schattgen SA, Fitzgerald KA. The PYHIN protein family as mediators of host defenses. Immunol Rev. 2011;243:109\u201318.","journal-title":"Immunol Rev"},{"key":"2164_CR52","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1073\/pnas.1203447109","volume":"109","author":"T Li","year":"2012","unstructured":"Li T, Diner BA, Chen J, Cristea IM. Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci U S A. 2012;109:10558\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2164_CR53","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.chom.2019.05.002","volume":"25","author":"D Hotter","year":"2019","unstructured":"Hotter D, Bosso M, Jonsson KL, et al. IFI16 targets the transcription factor Sp1 to suppress HIV-1 transcription and latency reactivation. Cell Host Microbe. 2019;25:858\u2013e872813.","journal-title":"Cell Host Microbe"},{"key":"2164_CR54","doi-asserted-by":"publisher","first-page":"e1008335","DOI":"10.1371\/journal.ppat.1008335","volume":"16","author":"W Wang","year":"2020","unstructured":"Wang W, Hu D, Wu C, et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 2020;16:e1008335.","journal-title":"PLoS Pathog"},{"key":"2164_CR55","doi-asserted-by":"publisher","first-page":"110138","DOI":"10.1016\/j.celrep.2021.110138","volume":"37","author":"NL Ka","year":"2021","unstructured":"Ka NL, Lim GY, Hwang S, et al. IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer. Cell Rep. 2021;37:110138.","journal-title":"Cell Rep"},{"key":"2164_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1158\/1541-7786.MCR-10-0565","volume":"9","author":"X Duan","year":"2011","unstructured":"Duan X, Ponomareva L, Veeranki S, et al. Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts. Mol Cancer Res. 2011;9:589\u2013602.","journal-title":"Mol Cancer Res"},{"key":"2164_CR57","doi-asserted-by":"crossref","unstructured":"Ekabe CJ, Clinton NA, Kehbila J, Franck NC. The Role of Inflammasome Activation in Early HIV Infection. J Immunol Res. 2021; 2021:1487287.","DOI":"10.1155\/2021\/1487287"},{"key":"2164_CR58","doi-asserted-by":"publisher","first-page":"35874","DOI":"10.1074\/jbc.M111.242321","volume":"286","author":"K Kersse","year":"2011","unstructured":"Kersse K, Lamkanfi M, Bertrand MJM, et al. Interaction patches of procaspase-1 caspase recruitment domains (CARDs) are differently involved in procaspase-1 activation and receptor-interacting protein 2 (RIP2)-dependent nuclear factor kappab signaling. J Biol Chem. 2011;286:35874\u201382.","journal-title":"J Biol Chem"},{"key":"2164_CR59","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1074\/jbc.RA118.004407","volume":"294","author":"RJT Nambayan","year":"2019","unstructured":"Nambayan RJT, Sandin SI, Quint DA, et al. The inflammasome adapter ASC assembles into filaments with integral participation of its two death Domains, PYD and CARD. J Biol Chem. 2019;294:439\u201352.","journal-title":"J Biol Chem"},{"key":"2164_CR60","doi-asserted-by":"publisher","first-page":"18419","DOI":"10.1074\/jbc.M116.718668","volume":"291","author":"R Stein","year":"2016","unstructured":"Stein R, Kapplusch F, Heymann MC, et al. Enzymatically inactive Procaspase 1 stabilizes the ASC pyroptosome and supports pyroptosome spreading during cell division. J Biol Chem. 2016;291:18419\u201329.","journal-title":"J Biol Chem"},{"key":"2164_CR61","doi-asserted-by":"crossref","unstructured":"Miao L, Wang H, Yang X et al. Methamphetamine and HIV-1 Tat Synergistically Induce Microglial Pyroptosis Via Activation of the AIM2 Inflammasome. Inflammation. 2025.","DOI":"10.1007\/s10753-025-02266-9"},{"key":"2164_CR62","doi-asserted-by":"publisher","first-page":"e1009417","DOI":"10.1371\/journal.ppat.1009417","volume":"17","author":"K Triantafilou","year":"2021","unstructured":"Triantafilou K, Ward CJK, Czubala M, et al. Differential recognition of HIV-stimulated IL-1beta and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages. PLoS Pathog. 2021;17:e1009417.","journal-title":"PLoS Pathog"},{"key":"2164_CR63","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3389\/fimmu.2018.02633","volume":"9","author":"DS Ojeda","year":"2018","unstructured":"Ojeda DS, Grasso D, Urquiza J, et al. Cell death is counteracted by mitophagy in HIV-Productively infected astrocytes but is promoted by inflammasome activation among Non-productively infected cells. Front Immunol. 2018;9:2633.","journal-title":"Front Immunol"},{"key":"2164_CR64","doi-asserted-by":"crossref","unstructured":"Kulsuptrakul J, Turcotte EA, Emerman M, Mitchell PS. A human-specific motif facilitates CARD8 inflammasome activation after HIV-1 infection. Elife 2023; 12.","DOI":"10.7554\/eLife.84108"},{"key":"2164_CR65","doi-asserted-by":"crossref","unstructured":"Wang Q, Gao H, Clark KM et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science 2021; 371.","DOI":"10.1126\/science.abe1707"},{"key":"2164_CR66","doi-asserted-by":"crossref","unstructured":"Kulsuptrakul J, Emerman M, Mitchell PS. CARD8 inflammasome activation during HIV-1 cell-to-cell transmission. eLife 2025; 13.","DOI":"10.7554\/eLife.102676.3"},{"key":"2164_CR67","doi-asserted-by":"publisher","first-page":"e1007907","DOI":"10.1371\/journal.ppat.1007907","volume":"15","author":"N Mukhamedova","year":"2019","unstructured":"Mukhamedova N, Hoang A, Dragoljevic D, et al. Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells. PLoS Pathog. 2019;15:e1007907.","journal-title":"PLoS Pathog"},{"key":"2164_CR68","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1084\/jem.20101805","volume":"208","author":"C Seror","year":"2011","unstructured":"Seror C, Melki MT, Subra F, et al. Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med. 2011;208:1823\u201334.","journal-title":"J Exp Med"},{"key":"2164_CR69","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1016\/j.celrep.2019.02.095","volume":"28","author":"A Paoletti","year":"2019","unstructured":"Paoletti A, Allouch A, Caillet M, et al. HIV-1 envelope overcomes NLRP3-Mediated Inhibition of F-Actin polymerization for viral entry. Cell Rep. 2019;28:3381\u2013e33943387.","journal-title":"Cell Rep"},{"key":"2164_CR70","doi-asserted-by":"publisher","first-page":"102358","DOI":"10.1016\/j.coph.2023.102358","volume":"69","author":"NR Rodriguez","year":"2023","unstructured":"Rodriguez NR, Fortune T, Vuong T, Swartz TH. The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1. Curr Opin Pharmacol. 2023;69:102358.","journal-title":"Curr Opin Pharmacol"},{"key":"2164_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41423-019-0260-y","volume":"17","author":"X He","year":"2020","unstructured":"He X, Yang W, Zeng Z, et al. NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology. Cell Mol Immunol. 2020;17:283\u201399.","journal-title":"Cell Mol Immunol"},{"key":"2164_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-Mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245\u201354.","journal-title":"Trends Biochem Sci"},{"key":"2164_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43556-025-00249-8","volume":"6","author":"Y Li","year":"2025","unstructured":"Li Y, Guo B. GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets. Mol Biomed. 2025;6:11.","journal-title":"Mol Biomed"},{"key":"2164_CR74","doi-asserted-by":"publisher","first-page":"eabl6781","DOI":"10.1126\/scisignal.abl6781","volume":"15","author":"B Zhou","year":"2022","unstructured":"Zhou B, Ryder CB, Dubyak GR, Abbott DW. Gasdermins and pannexin-1 mediate pathways of chemotherapy-induced cell Lysis in hematopoietic malignancies. Sci Signal. 2022;15:eabl6781.","journal-title":"Sci Signal"},{"key":"2164_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","volume":"591","author":"N Kayagaki","year":"2021","unstructured":"Kayagaki N, Kornfeld OS, Lee BL, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 2021;591:131\u20136.","journal-title":"Nature"},{"key":"2164_CR76","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41586-023-05991-z","volume":"618","author":"M Degen","year":"2023","unstructured":"Degen M, Santos JC, Pluhackova K, et al. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature. 2023;618:1065\u201371.","journal-title":"Nature"},{"key":"2164_CR77","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","volume":"187","author":"P Rider","year":"2011","unstructured":"Rider P, Carmi Y, Guttman O, et al. IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol. 2011;187:4835\u201343.","journal-title":"J Immunol"},{"key":"2164_CR78","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.4049\/jimmunol.170.2.1084","volume":"170","author":"M Komai-Koma","year":"2003","unstructured":"Komai-Koma M, Gracie JA, Wei XQ, et al. Chemoattraction of human T cells by IL-18. J Immunol. 2003;170:1084\u201390.","journal-title":"J Immunol"},{"key":"2164_CR79","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","volume":"4","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.","journal-title":"Front Immunol"},{"key":"2164_CR80","first-page":"101046","volume":"27","author":"T Kihara","year":"2021","unstructured":"Kihara T, Toriuchi K, Aoki H, et al. Interleukin-1beta enhances cell adhesion in human endothelial cells via microRNA-1914-5p suppression. Biochem Biophys Rep. 2021;27:101046.","journal-title":"Biochem Biophys Rep"},{"key":"2164_CR81","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/s41467-017-02055-5","volume":"8","author":"I Goldstein","year":"2017","unstructured":"Goldstein I, Paakinaho V, Baek S, et al. Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading. Nat Commun. 2017;8:1849.","journal-title":"Nat Commun"},{"key":"2164_CR82","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fimmu.2018.00161","volume":"9","author":"M Bachmann","year":"2018","unstructured":"Bachmann M, Pfeilschifter J, Muhl H. A prominent role of Interleukin-18 in Acetaminophen-Induced liver injury advocates its blockage for therapy of hepatic necroinflammation. Front Immunol. 2018;9:161.","journal-title":"Front Immunol"},{"key":"2164_CR83","doi-asserted-by":"publisher","first-page":"e0192845","DOI":"10.1371\/journal.pone.0192845","volume":"13","author":"MG Feria","year":"2018","unstructured":"Feria MG, Taborda NA, Hernandez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1beta, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS ONE. 2018;13:e0192845.","journal-title":"PLoS ONE"},{"key":"2164_CR84","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/infdis\/jiu125","volume":"210","author":"CL Shive","year":"2014","unstructured":"Shive CL, Mudd JC, Funderburg NT, et al. Inflammatory cytokines drive CD4\u2009+\u2009T-cell cycling and impaired responsiveness to Interleukin 7: implications for immune failure in HIV disease. J Infect Dis. 2014;210:619\u201329.","journal-title":"J Infect Dis"},{"key":"2164_CR85","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/ars.2015.6407","volume":"23","author":"K Nakahira","year":"2015","unstructured":"Nakahira K, Hisata S, Choi AM. The roles of mitochondrial Damage-Associated molecular patterns in diseases. Antioxid Redox Signal. 2015;23:1329\u201350.","journal-title":"Antioxid Redox Signal"},{"key":"2164_CR86","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","volume":"22","author":"S Paik","year":"2025","unstructured":"Paik S, Kim JK, Shin HJ, et al. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol Immunol. 2025;22:563\u201396.","journal-title":"Cell Mol Immunol"},{"key":"2164_CR87","doi-asserted-by":"crossref","unstructured":"Hoel H, Dahl TB, Yang K et al. Chronic HIV infection increases monocyte NLRP3 Inflammasome-Dependent IL-1alpha and IL-1beta release. Int J Mol Sci 2024; 25.","DOI":"10.3390\/ijms25137141"},{"key":"2164_CR88","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen L, Patel O, Corbett AJ, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491:717\u201323.","journal-title":"Nature"},{"key":"2164_CR89","first-page":"24","volume":"9","author":"P Xia","year":"2022","unstructured":"Xia P, Xing XD, Yang CX, et al. Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients. Mil Med Res. 2022;9:24.","journal-title":"Mil Med Res"},{"key":"2164_CR90","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1182\/blood-2012-06-436436","volume":"121","author":"C Cosgrove","year":"2013","unstructured":"Cosgrove C, Ussher JE, Rauch A, et al. Early and nonreversible decrease of CD161++ \/MAIT cells in HIV infection. Blood. 2013;121:951\u201361.","journal-title":"Blood"},{"key":"2164_CR91","doi-asserted-by":"publisher","first-page":"e111323","DOI":"10.1371\/journal.pone.0111323","volume":"9","author":"JM Eberhard","year":"2014","unstructured":"Eberhard JM, Hartjen P, Kummer S, et al. CD161\u2009+\u2009MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS ONE. 2014;9:e111323.","journal-title":"PLoS ONE"},{"key":"2164_CR92","doi-asserted-by":"publisher","first-page":"eaaz0374","DOI":"10.1126\/sciadv.aaz0374","volume":"6","author":"X Tang","year":"2020","unstructured":"Tang X, Zhang S, Peng Q, et al. Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection. Sci Adv. 2020;6:eaaz0374.","journal-title":"Sci Adv"},{"key":"2164_CR93","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41467-019-13975-9","volume":"11","author":"KG Lal","year":"2020","unstructured":"Lal KG, Kim D, Costanzo MC, et al. Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection. Nat Commun. 2020;11:272.","journal-title":"Nat Commun"},{"key":"2164_CR94","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2012-07-445429","volume":"121","author":"E Leeansyah","year":"2013","unstructured":"Leeansyah E, Ganesh A, Quigley MF, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013;121:1124\u201335.","journal-title":"Blood"},{"key":"2164_CR95","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ni.3854","volume":"18","author":"O Rouxel","year":"2017","unstructured":"Rouxel O, Da Silva J, Beaudoin L, et al. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol. 2017;18:1321\u201331.","journal-title":"Nat Immunol"},{"key":"2164_CR96","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/cpt.363","volume":"99","author":"SX Li","year":"2016","unstructured":"Li SX, Armstrong A, Neff CP, et al. Complexities of gut Microbiome dysbiosis in the context of HIV infection and antiretroviral therapy. Clin Pharmacol Ther. 2016;99:600\u201311.","journal-title":"Clin Pharmacol Ther"},{"key":"2164_CR97","doi-asserted-by":"publisher","first-page":"193ra191","DOI":"10.1126\/scitranslmed.3006438","volume":"5","author":"I Vujkovic-Cvijin","year":"2013","unstructured":"Vujkovic-Cvijin I, Dunham RM, Iwai S, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and Tryptophan catabolism. Sci Transl Med. 2013;5:193ra191.","journal-title":"Sci Transl Med"},{"key":"2164_CR98","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41467-020-16222-8","volume":"11","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sortino O, Verheij E, et al. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat Commun. 2020;11:2448.","journal-title":"Nat Commun"},{"key":"2164_CR99","doi-asserted-by":"crossref","unstructured":"Pan Z, Wu N, Jin C. Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients. Can J Infect Dis Med Microbiol. 2023; 2023:3080969.","DOI":"10.1155\/2023\/3080969"},{"key":"2164_CR100","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41467-023-44566-4","volume":"15","author":"M Rocafort","year":"2024","unstructured":"Rocafort M, Gootenberg DB, Luevano JM Jr., et al. HIV-associated gut microbial alterations are dependent on host and geographic context. Nat Commun. 2024;15:1055.","journal-title":"Nat Commun"},{"key":"2164_CR101","doi-asserted-by":"publisher","first-page":"594820","DOI":"10.3389\/fmicb.2020.594820","volume":"11","author":"ST Geng","year":"2020","unstructured":"Geng ST, Zhang ZY, Wang YX, et al. Regulation of gut microbiota on immune reconstitution in patients with acquired immunodeficiency syndrome. Front Microbiol. 2020;11:594820.","journal-title":"Front Microbiol"},{"key":"2164_CR102","doi-asserted-by":"crossref","unstructured":"Gaspar Z, Nagavci B, Szabo BG, Lakatos B. Gut Microbiome alteration in HIV\/AIDS and the role of antiretroviral Therapy-A scoping review. Microorganisms 2024; 12.","DOI":"10.37766\/inplasy2024.10.0046"},{"key":"2164_CR103","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)-Mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"2164_CR104","doi-asserted-by":"publisher","first-page":"e2100408","DOI":"10.1002\/mnfr.202100408","volume":"66","author":"J Xie","year":"2022","unstructured":"Xie J, Li LF, Dai TY, et al. Short-Chain fatty acids produced by Ruminococcaceae mediate alpha-Linolenic acid promote intestinal stem cells proliferation. Mol Nutr Food Res. 2022;66:e2100408.","journal-title":"Mol Nutr Food Res"},{"key":"2164_CR105","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mce.2022.111572","volume":"546","author":"KJ O\u2019Riordan","year":"2022","unstructured":"O\u2019Riordan KJ, Collins MK, Moloney GM, et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572.","journal-title":"Mol Cell Endocrinol"},{"key":"2164_CR106","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/QAD.0000000000003812","volume":"38","author":"J Zhou","year":"2024","unstructured":"Zhou J, Yang Y, Xie Z, et al. Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4\u2009+\u2009T cell reduction and immune activation. AIDS. 2024;38:633\u201344.","journal-title":"AIDS"},{"key":"2164_CR107","doi-asserted-by":"publisher","first-page":"e1006202","DOI":"10.1371\/journal.ppat.1006202","volume":"13","author":"E Maidji","year":"2017","unstructured":"Maidji E, Somsouk M, Rivera JM, et al. Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. PLoS Pathog. 2017;13:e1006202.","journal-title":"PLoS Pathog"},{"key":"2164_CR108","doi-asserted-by":"publisher","first-page":"e0119568","DOI":"10.1371\/journal.pone.0119568","volume":"10","author":"M Marquez","year":"2015","unstructured":"Marquez M, Romero-Cores P, Montes-Oca M, et al. Immune activation response in chronic HIV-infected patients: influence of hepatitis C virus coinfection. PLoS ONE. 2015;10:e0119568.","journal-title":"PLoS ONE"},{"key":"2164_CR109","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1186\/s12879-022-07818-0","volume":"22","author":"X Lao","year":"2022","unstructured":"Lao X, Mei X, Zou J, et al. Pyroptosis associated with immune reconstruction failure in HIV-1- infected patients receiving antiretroviral therapy: a cross-sectional study. BMC Infect Dis. 2022;22:867.","journal-title":"BMC Infect Dis"},{"key":"2164_CR110","first-page":"31","volume":"12","author":"D Torre","year":"2010","unstructured":"Torre D, Pugliese A. Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime? AIDS Rev. 2010;12:31\u20139.","journal-title":"AIDS Rev"},{"key":"2164_CR111","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/labinvest.2009.29","volume":"89","author":"JH Yearley","year":"2009","unstructured":"Yearley JH, Xia D, Pearson CB, et al. Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat\/high-cholesterol diet. Lab Invest. 2009;89:657\u201367.","journal-title":"Lab Invest"},{"key":"2164_CR112","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1161\/ATVBAHA.119.312603","volume":"39","author":"AC Kearns","year":"2019","unstructured":"Kearns AC, Liu F, Dai S, et al. Caspase-1 activation is related with HIV-Associated atherosclerosis in an HIV Transgenic mouse model and HIV patient cohort. Arterioscler Thromb Vasc Biol. 2019;39:1762\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2164_CR113","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/2047487312447843","volume":"20","author":"A Maniar","year":"2013","unstructured":"Maniar A, Ellis C, Asmuth D, et al. HIV infection and atherosclerosis: evaluating the drivers of inflammation. Eur J Prev Cardiol. 2013;20:720\u20138.","journal-title":"Eur J Prev Cardiol"},{"key":"2164_CR114","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fcvm.2020.00095","volume":"7","author":"C Mullis","year":"2020","unstructured":"Mullis C, Swartz TH. NLRP3 inflammasome signaling as a link between HIV-1 infection and atherosclerotic cardiovascular disease. Front Cardiovasc Med. 2020;7:95.","journal-title":"Front Cardiovasc Med"},{"key":"2164_CR115","doi-asserted-by":"publisher","first-page":"C487","DOI":"10.1152\/ajpcell.00600.2023","volume":"326","author":"N Fattakhov","year":"2024","unstructured":"Fattakhov N, Ngo A, Torices S, et al. Cenicriviroc prevents dysregulation of astrocyte\/endothelial cross talk induced by ischemia and HIV-1 via inhibiting the NLRP3 inflammasome and pyroptosis. Am J Physiol Cell Physiol. 2024;326:C487\u2013504.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2164_CR116","doi-asserted-by":"publisher","first-page":"e12563","DOI":"10.1111\/cpr.12563","volume":"52","author":"Z Zhaolin","year":"2019","unstructured":"Zhaolin Z, Guohua L, Shiyuan W, Zuo W. Role of pyroptosis in cardiovascular disease. Cell Prolif. 2019;52:e12563.","journal-title":"Cell Prolif"},{"key":"2164_CR117","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ajpath.2015.10.002","volume":"186","author":"S Haque","year":"2016","unstructured":"Haque S, Lan X, Wen H, et al. HIV promotes NLRP3 inflammasome complex activation in murine HIV-Associated nephropathy. Am J Pathol. 2016;186:347\u201358.","journal-title":"Am J Pathol"},{"key":"2164_CR118","doi-asserted-by":"publisher","first-page":"e1004665","DOI":"10.1371\/journal.pcbi.1004665","volume":"11","author":"S Wang","year":"2015","unstructured":"Wang S, Hottz P, Schechter M, Rong L. Modeling the slow CD4\u2009+\u2009T cell decline in HIV-Infected individuals. PLoS Comput Biol. 2015;11:e1004665.","journal-title":"PLoS Comput Biol"},{"key":"2164_CR119","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1038\/s41598-017-04130-9","volume":"7","author":"D Wodarz","year":"2017","unstructured":"Wodarz D, Levy DN. Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection. Sci Rep. 2017;7:3834.","journal-title":"Sci Rep"},{"key":"2164_CR120","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/COH.0000000000000837","volume":"19","author":"MR Pinzone","year":"2024","unstructured":"Pinzone MR, Shan L. Pharmacological approaches to promote cell death of latent HIV reservoirs. Curr Opin HIV AIDS. 2024;19:56\u201361.","journal-title":"Curr Opin HIV AIDS"},{"key":"2164_CR121","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/cid\/ciq202","volume":"52","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Hatano H, Sinclair E, et al. HIV-specific CD4\u2009+\u2009T cells May contribute to viral persistence in HIV controllers. Clin Infect Dis. 2011;52:681\u20137.","journal-title":"Clin Infect Dis"},{"key":"2164_CR122","doi-asserted-by":"publisher","first-page":"123ps124","DOI":"10.1126\/scitranslmed.3003862","volume":"4","author":"NR Klatt","year":"2012","unstructured":"Klatt NR, Silvestri G. CD4\u2009+\u2009T cells and HIV: A Paradoxical Pas de Deux. Sci Transl Med. 2012;4:123ps124.","journal-title":"Sci Transl Med"},{"key":"2164_CR123","doi-asserted-by":"crossref","unstructured":"Amand M, Adams P, Schober R et al. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4(+) T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice. Elife 2023; 12.","DOI":"10.7554\/eLife.83207"},{"key":"2164_CR124","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12977-024-00641-2","volume":"21","author":"AJ Holloway","year":"2024","unstructured":"Holloway AJ, Saito TB, Naqvi KF, et al. Inhibition of caspase pathways limits CD4(+) T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissue. Retrovirology. 2024;21:8.","journal-title":"Retrovirology"},{"key":"2164_CR125","doi-asserted-by":"publisher","first-page":"108266","DOI":"10.1016\/j.clim.2019.108266","volume":"209","author":"EC Reis","year":"2019","unstructured":"Reis EC, Leal VNC, da Silva LT, et al. Antagonistic role of IL-1ss and NLRP3\/IL-18 genetics in chronic HIV-1 infection. Clin Immunol. 2019;209:108266.","journal-title":"Clin Immunol"},{"key":"2164_CR126","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/iji.12157","volume":"41","author":"T Booiman","year":"2014","unstructured":"Booiman T, Kootstra NA. Polymorphism in IFI16 affects CD4(+) T-cell counts in HIV-1 infection. Int J Immunogenet. 2014;41:518\u201320.","journal-title":"Int J Immunogenet"},{"key":"2164_CR127","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1742-4690-11-35","volume":"11","author":"JG Walsh","year":"2014","unstructured":"Walsh JG, Reinke SN, Mamik MK, et al. Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS. Retrovirology. 2014;11:35.","journal-title":"Retrovirology"},{"key":"2164_CR128","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.celrep.2016.09.023","volume":"17","author":"J Vermeire","year":"2016","unstructured":"Vermeire J, Roesch F, Sauter D, et al. HIV triggers a cGAS-Dependent, Vpu- and Vpr-Regulated type I interferon response in CD4(+) T cells. Cell Rep. 2016;17:413\u201324.","journal-title":"Cell Rep"},{"key":"2164_CR129","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molimm.2022.04.018","volume":"148","author":"LJ Galvao-Lima","year":"2022","unstructured":"Galvao-Lima LJ, Zambuzi FA, Soares LS, et al. HIV-1 gag and Vpr impair the inflammasome activation and contribute to the establishment of chronic infection in human primary macrophages. Mol Immunol. 2022;148:68\u201380.","journal-title":"Mol Immunol"},{"key":"2164_CR130","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","volume":"12","author":"MK Mamik","year":"2017","unstructured":"Mamik MK, Hui E, Branton WG, et al. HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation. J Neuroimmune Pharmacol. 2017;12:233\u201348.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2164_CR131","doi-asserted-by":"publisher","first-page":"e0075521","DOI":"10.1128\/Spectrum.00755-21","volume":"9","author":"A Ramachandran","year":"2021","unstructured":"Ramachandran A, Kumar B, Waris G, Everly D. Deubiquitination and activation of the NLRP3 inflammasome by UCHL5 in HCV-Infected cells. Microbiol Spectr. 2021;9:e0075521.","journal-title":"Microbiol Spectr"},{"key":"2164_CR132","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.bbadis.2016.12.006","volume":"1863","author":"NS Farag","year":"2017","unstructured":"Farag NS, Breitinger U, El-Azizi M, Breitinger HG. The p7 Viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1beta. Biochim Biophys Acta Mol Basis Dis. 2017;1863:712\u201320.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2164_CR133","doi-asserted-by":"crossref","unstructured":"Bittner ZA, Schrader M, George SE, Amann R. Pyroptosis and its role in SARS-CoV-2 infection. Cells 2022; 11.","DOI":"10.3390\/cells11101717"},{"key":"2164_CR134","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.7150\/ijbs.77561","volume":"18","author":"M Wang","year":"2022","unstructured":"Wang M, Chang W, Zhang L, Zhang Y. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the Immunopathogenesis of COVID-19. Int J Biol Sci. 2022;18:5827\u201348.","journal-title":"Int J Biol Sci"},{"key":"2164_CR135","doi-asserted-by":"publisher","first-page":"e50421","DOI":"10.15252\/embr.202050421","volume":"21","author":"I Boal-Carvalho","year":"2020","unstructured":"Boal-Carvalho I, Mazel-Sanchez B, Silva F, et al. Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages. EMBO Rep. 2020;21:e50421.","journal-title":"EMBO Rep"},{"key":"2164_CR136","doi-asserted-by":"publisher","first-page":"27912","DOI":"10.1038\/srep27912","volume":"6","author":"MD Tate","year":"2016","unstructured":"Tate MD, Ong JDH, Dowling JK, et al. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via Temporal Inhibition. Sci Rep. 2016;6:27912.","journal-title":"Sci Rep"},{"key":"2164_CR137","doi-asserted-by":"publisher","first-page":"ofad539","DOI":"10.1093\/ofid\/ofad539","volume":"10","author":"R Nabatanzi","year":"2023","unstructured":"Nabatanzi R, Ssekamatte P, Castelnuovo B, et al. Increased levels of Caspase-1 and IL-1beta among adults with persistent immune activation after 12 years of suppressive antiretroviral therapy in the infectious diseases Institute HIV treatment cohort. Open Forum Infect Dis. 2023;10:ofad539.","journal-title":"Open Forum Infect Dis"},{"key":"2164_CR138","doi-asserted-by":"crossref","unstructured":"Caocci M, Niu M, Fox HS, Burdo TH. HIV infection drives foam cell formation via NLRP3 inflammasome activation. Int J Mol Sci 2024; 25.","DOI":"10.3390\/ijms25042367"},{"key":"2164_CR139","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/infdis\/jiq118","volume":"203","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780\u201390.","journal-title":"J Infect Dis"},{"key":"2164_CR140","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00018-025-05685-x","volume":"82","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tan B, Tang T, et al. Targeting inflammasomes as a therapeutic potential for HIV\/AIDS. Cell Mol Life Sci. 2025;82:162.","journal-title":"Cell Mol Life Sci"},{"key":"2164_CR141","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","volume":"25","author":"RC Coll","year":"2025","unstructured":"Coll RC, Schroder K. Inflammasome components as new therapeutic targets in inflammatory disease. Nat Rev Immunol. 2025;25:22\u201341.","journal-title":"Nat Rev Immunol"},{"key":"2164_CR142","doi-asserted-by":"publisher","first-page":"634607","DOI":"10.3389\/fcell.2021.634607","volume":"9","author":"S Wei","year":"2021","unstructured":"Wei S, Ma W, Zhang B, Li W. NLRP3 inflammasome: A promising therapeutic target for Drug-Induced toxicity. Front Cell Dev Biol. 2021;9:634607.","journal-title":"Front Cell Dev Biol"},{"key":"2164_CR143","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kluck","year":"2020","unstructured":"Kluck V, Jansen T, Janssen M, et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2:e270\u201380.","journal-title":"Lancet Rheumatol"},{"key":"2164_CR144","doi-asserted-by":"publisher","first-page":"13524","DOI":"10.1038\/s41598-023-39805-z","volume":"13","author":"G Ambrus-Aikelin","year":"2023","unstructured":"Ambrus-Aikelin G, Takeda K, Joetham A, et al. JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders. Sci Rep. 2023;13:13524.","journal-title":"Sci Rep"},{"key":"2164_CR145","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y, et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med. 2017;214:3219\u201338.","journal-title":"J Exp Med"},{"key":"2164_CR146","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9:2550.","journal-title":"Nat Commun"},{"key":"2164_CR147","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41420-024-01978-5","volume":"10","author":"X Chang","year":"2024","unstructured":"Chang X, Wang B, Zhao Y, et al. The role of IFI16 in regulating PANoptosis and implication in heart diseases. Cell Death Discov. 2024;10:204.","journal-title":"Cell Death Discov"},{"key":"2164_CR148","doi-asserted-by":"publisher","first-page":"103714","DOI":"10.1016\/j.isci.2021.103714","volume":"25","author":"S Mishra","year":"2022","unstructured":"Mishra S, Raj AS, Kumar A, et al. Innate immune sensing of influenza A viral RNA through IFI16 promotes pyroptotic cell death. iScience. 2022;25:103714.","journal-title":"iScience"},{"key":"2164_CR149","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1038\/s41598-020-64348-y","volume":"10","author":"C Wiser","year":"2020","unstructured":"Wiser C, Kim B, Vincent J, Ascano M. Small molecule Inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells. Sci Rep. 2020;10:7604.","journal-title":"Sci Rep"},{"key":"2164_CR150","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41392-021-00650-z","volume":"6","author":"Y Li","year":"2021","unstructured":"Li Y, Huang H, Liu B, et al. Inflammasomes as therapeutic targets in human diseases. Signal Transduct Target Ther. 2021;6:247.","journal-title":"Signal Transduct Target Ther"},{"key":"2164_CR151","doi-asserted-by":"publisher","first-page":"e1197","DOI":"10.1002\/iid3.1197","volume":"12","author":"S Zhou","year":"2024","unstructured":"Zhou S, Yang X, Mo K, Ning Z. Pyroptosis and polarization of macrophages in septic acute lung injury induced by lipopolysaccharide in mice. Immun Inflamm Dis. 2024;12:e1197.","journal-title":"Immun Inflamm Dis"},{"key":"2164_CR152","doi-asserted-by":"publisher","first-page":"101718","DOI":"10.1016\/j.tice.2021.101718","volume":"75","author":"H Lyu","year":"2022","unstructured":"Lyu H, Ni H, Huang J, et al. VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome. Tissue Cell. 2022;75:101718.","journal-title":"Tissue Cell"},{"key":"2164_CR153","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","volume":"9","author":"G Cavalli","year":"2018","unstructured":"Cavalli G, Dinarello CA. Anakinra therapy for Non-cancer inflammatory diseases. Front Pharmacol. 2018;9:1157.","journal-title":"Front Pharmacol"},{"key":"2164_CR154","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.chembiol.2024.10.002","volume":"31","author":"Y Hu","year":"2024","unstructured":"Hu Y, Li H, Zhang X, et al. Identification of two repurposed drugs targeting GSDMD oligomerization interface I to block pyroptosis. Cell Chem Biol. 2024;31:2024\u201338. e2027.","journal-title":"Cell Chem Biol"},{"key":"2164_CR155","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41419-025-07475-6","volume":"16","author":"X Chu","year":"2025","unstructured":"Chu X, Zhang T, Bukhari I, et al. Ubiquitination of gasdermin D N-terminal domain directs its membrane translocation and pore formation during pyroptosis. Cell Death Dis. 2025;16:181.","journal-title":"Cell Death Dis"},{"key":"2164_CR156","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/eurheartj\/ehaf024","volume":"46","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Martsch P, Chen X, et al. Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis. Eur Heart J. 2025;46:1250\u201362.","journal-title":"Eur Heart J"},{"key":"2164_CR157","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41419-022-05138-4","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li Y, Chen Z, et al. GSDMD-dependent neutrophil extracellular traps promote macrophage-to-myofibroblast transition and renal fibrosis in obstructive nephropathy. Cell Death Dis. 2022;13:693.","journal-title":"Cell Death Dis"},{"key":"2164_CR158","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, et al. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020;369:1633\u20137.","journal-title":"Science"},{"key":"2164_CR159","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cmdc.200900531","volume":"5","author":"MB Boxer","year":"2010","unstructured":"Boxer MB, Quinn AM, Shen M, et al. A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. ChemMedChem. 2010;5:730\u20138.","journal-title":"ChemMedChem"},{"key":"2164_CR160","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, et al. FDA-approved Disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21:736\u201345.","journal-title":"Nat Immunol"},{"key":"2164_CR161","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.smim.2023.101845","volume":"70","author":"B Zhou","year":"2023","unstructured":"Zhou B, Abbott DW. Chemical modulation of gasdermin D activity: therapeutic implications and consequences. Semin Immunol. 2023;70:101845.","journal-title":"Semin Immunol"},{"key":"2164_CR162","doi-asserted-by":"publisher","first-page":"6792","DOI":"10.1073\/pnas.1800562115","volume":"115","author":"J Yang","year":"2018","unstructured":"Yang J, Liu Z, Wang C, et al. Mechanism of gasdermin D recognition by inflammatory caspases and their Inhibition by a gasdermin D-derived peptide inhibitor. Proc Natl Acad Sci U S A. 2018;115:6792\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2164_CR163","doi-asserted-by":"crossref","unstructured":"Bettiol A, Lopalco G, Emmi G et al. Unveiling the Efficacy, Safety, and tolerability of Anti-Interleukin-1 treatment in Monogenic and multifactorial autoinflammatory diseases. Int J Mol Sci 2019; 20.","DOI":"10.3390\/ijms20081898"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02164-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T20:02:15Z","timestamp":1768161735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02164-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02164-8","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}